These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

749 related items for PubMed ID: 27667012

  • 1. Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Busca A, Candoni A, Audisio E, Passera R, Bruno B, Monaco F, Mordini N, Vacca A, Delia M, Aversa F, Pagano L.
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2214-2219. PubMed ID: 27667012
    [Abstract] [Full Text] [Related]

  • 2. Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.
    Cho SY, Lee DG, Choi JK, Lee HJ, Kim SH, Park SH, Choi SM, Choi JH, Yoo JH, Kim YJ, Kim HJ, Min WS, Back H, Kang S, Lee EK.
    Clin Ther; 2015 Sep; 37(9):2019-27. PubMed ID: 26188835
    [Abstract] [Full Text] [Related]

  • 3. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
    Busca A, Cinatti N, Gill J, Passera R, Dellacasa CM, Giaccone L, Dogliotti I, Manetta S, Corcione S, De Rosa FG.
    Front Cell Infect Microbiol; 2021 Sep; 11():805514. PubMed ID: 35071052
    [Abstract] [Full Text] [Related]

  • 4. Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country.
    Korula A, Abraham A, Abubacker FN, Viswabandya A, Lakshmi KM, Abraham OC, Rupali P, Varghese GM, Michael JS, Srivastava A, Mathews V, George B.
    Mycoses; 2017 Oct; 60(10):686-691. PubMed ID: 28736936
    [Abstract] [Full Text] [Related]

  • 5. Itraconazole vs. posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia undergoing intensive chemotherapy: A retrospective study.
    Copley MS, Waldron M, Athans V, Welch SC, Brizendine KD, Cober E, Siebenaller C.
    Int J Antimicrob Agents; 2020 Mar; 55(3):105886. PubMed ID: 31926286
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
    Dahlén T, Kalin M, Cederlund K, Nordlander A, Björkholm M, Ljungman P, Blennow O.
    Eur J Haematol; 2016 Feb; 96(2):175-80. PubMed ID: 25880378
    [Abstract] [Full Text] [Related]

  • 13. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
    Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D.
    N Engl J Med; 2007 Jan 25; 356(4):348-59. PubMed ID: 17251531
    [Abstract] [Full Text] [Related]

  • 14. Impact of fluconazole versus posaconazole prophylaxis on the incidence of fungal infections in patients receiving induction chemotherapy for acute myeloid leukemia.
    Devanlay C, Tavernier-Tardy E, Bourmaud A, Falk AT, Raberin H, Menguy S, Guyotat D, Magné N, Cornillon J.
    Biomed J; 2015 Jan 25; 38(3):235-43. PubMed ID: 25355388
    [Abstract] [Full Text] [Related]

  • 15. Comparison of invasive fungal diseases between patients with acute myeloid leukemia receiving posaconazole prophylaxis and those not receiving prophylaxis: A single-center, observational, case-control study in South Korea.
    Yang E, Choi EJ, Park HS, Lee SO, Choi SH, Kim YS, Lee JH, Lee JH, Lee KH, Kim SH.
    Medicine (Baltimore); 2021 May 21; 100(20):e25448. PubMed ID: 34011022
    [Abstract] [Full Text] [Related]

  • 16. Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations.
    Cho SY, Lee DG, Choi SM, Choi JK, Lee HJ, Kim SH, Park SH, Choi JH, Yoo JH, Kim YJ, Kim HJ, Min WS.
    Mycoses; 2015 Sep 21; 58(9):565-71. PubMed ID: 26214656
    [Abstract] [Full Text] [Related]

  • 17. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.
    Bone Marrow Transplant; 2006 Jul 21; 38(2):127-34. PubMed ID: 16751782
    [Abstract] [Full Text] [Related]

  • 18. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation in First Complete Remission Can Abrogate the Poor Outcomes of Children with Acute Myeloid Leukemia Resistant to the First Course of Induction Chemotherapy.
    Mo XD, Zhang XH, Xu LP, Wang Y, Yan CH, Chen H, Chen YH, Han W, Wang FR, Wang JZ, Liu KY, Huang XJ.
    Biol Blood Marrow Transplant; 2016 Dec 21; 22(12):2235-2242. PubMed ID: 27614057
    [Abstract] [Full Text] [Related]

  • 19. A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
    Sarina B, Mariotti J, Bramanti S, Morabito L, Crocchiolo R, Rimondo A, Tordato F, Pocaterra D, Casari E, De Philippis C, Carlo-Stella C, Santoro A, Castagna L.
    Transpl Infect Dis; 2018 Aug 21; 20(4):e12906. PubMed ID: 29668124
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantation.
    Sánchez-Ortega I, Patiño B, Muñoz C, Arnan M, Peralta T, Clopés A, de Sevilla AF, Duarte RF.
    J Med Econ; 2013 Aug 21; 16(6):736-43. PubMed ID: 23541251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.